Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

University of Saskatchewan

120 Veterinary Road

Saskatoon, SK S7N 5E3
General contact
Paul Hodgson
Associate Director

Business Development

T: (306) 966-7465
Research contact
Paul Hodgson
Associate Director

Business Development

T: (306) 966-7465
Lab/facility website:
Published date: Nov 26, 2013
Last updated: Apr 04, 2016
What the lab/facility does

Vaccine development and testing, containment 2 and 3 infectious disease research, large animal models of disease, preclinical trials, regulatory trials.

Sectors of Application
Defense and security industries; Fisheries and aquaculture; Health care and social services
Area(s) of expertise

VIDO-InterVac is one of Canada’s premier research institutes, with more than 35 years of experience in infectious disease research and vaccine development for animals and humans. VIDO-InterVac has more than 150 personnel and some of the world’s most advanced containment infrastructure, including containment level 2 and level 3 animal housing and laboratories, a select agent lab, an aerobiology challenge unit, and a 160-acre containment level 2 research station. The unique $140-million large animal containment level 3 laboratory became operational in 2013. VIDO-InterVac can complete multiple stages of vaccine development including pre-clinical trials for human vaccines and full regulatory and efficacy trials for animal vaccines.

Research Services

Pathogenomics, proteomics, metabolomics, kinomics, antigen identification, vaccine development, vaccine formulation and delivery, animal disease models (containment 2 and 3), preclinical vaccine testing (human), regulatory vaccine testing (animals)

Specialized labs and equipment

Name of specialized lab

Name of equipment

Description of function



Level 2

100,000 square feet of level 2 lab space and additional 20,000 square feet of level 2 animal isolation

Level 3

18 containment level 3 animal suites and 6 containment level 3 laboratories.  Animal suites can hold all species including up to 160 cattle under CL3.

Research station

160-acre Research Station

Research station certified to containment level 2 able to conduct large animal studies including efficacy trials on horses and cattle.

VIDO-InterVac – CL3 aerobiology lab

Madison Chamber, fully suited

Fully suited lab for aerobiology challenge experiments including Canada’s only Madison chamber for aerobiology challenge experiments.

VIDO-InterVac – select agent lab

Class 3 Glovebox

Provides infrastructure required to work with select agents as qualified by the Centers for Disease Control.

Private and public sector research partners
  • Bill & Melinda Gates Foundation
  • Boehringer Ingelheim Vetmedica
  • Canadian Centre for Vaccinology
  • Cangene Corporation
  • Centre for Drug Research and Development
  • CEVA
  • Department of National Defence
  • Elanco
  • Health Sciences North
  • International Livestock Research Institute
  • International Vaccine Institute
  • Kenyan Agricultural and Livestock Research Organization
  • Maple Leaf Foods
  • Meadow Ridge Enterprises
  • Merial Limited
  • National Veterinary Research and Quarantine Service
  • Novartis Animal Health
  • Pan-Provincial Vaccine Enterprise
  • Prevtec Microbia
  • Telesta
  • World Health Organization (WHO)

Technicians working in containment level 3

Credit: Debra Marshall photography

Additional Information



Funding awarded to develop vaccines for bovine tuberculosis and Johne’s disease’s-disease

Government of Canada announces funding to enhance influenza vaccine research and development

Federal Regulators Give InterVac Stamp of Approval

U of S, Kenyan and Ethiopian scientists partner on $5.3 million in projects to combat hunger

Saving Lives Through Vaccine Research

U of S International Vaccine Centre Celebrates Grand Opening